MM120
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
ADHD
Conditions
ADHD, Attention Deficit Disorder
Trial Timeline
Dec 17, 2021 → Dec 4, 2023
NCT ID
NCT05200936About MM120
MM120 is a phase 2 stage product being developed by Definium Therapeutics for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT05200936. Target conditions include ADHD, Attention Deficit Disorder.
What happened to similar drugs?
10 of 20 similar drugs in ADHD were approved
Approved (10) Terminated (2) Active (10)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05407064 | Phase 2 | Completed |
| NCT05200936 | Phase 2 | Completed |
Competing Products
20 competing products in ADHD